Crowley Law LLC - May 2025

The same is true of our work with technology companies. We have successfully represented newly formed companies in acquiring, financing, and achieving critical milestones. Our firm doesn’t just succeed through our expertise and experience in law and science; we thrive because we celebrate and support the innovators we are privileged to represent. My career up to this point — and the path that led me to start my firm — has been anything but a straight line, but the same can be said for anyone striving to go from lab to patient or from garage to market. My firm and I are here to help you reach your fullest potential because my lawyers and I are people who get it . If you’re a past or current client, I thank you for your trust and ... continued from Cover

From Lab to Patient, Garage to Market Drug Development With Ray Sison

If you’re unfamiliar with Philip Crowley’s “From Lab to Patient, Garage to Market” podcast, Episode 17 is one of several recent installments worth checking out! Ray Sison, managing partner of the drug development consulting firm SCxCMC Solutions, joins Philip for an engaging discussion on some of

confidence in what Crowley Law LLC offers. If you’re new to our services, I can’t wait to help you move your inventiveness and ingenuity toward a bright future.

–Philip Crowley

the critical steps required to introduce products to the consumer market. The conversation addresses various topics, including some of the many challenges facing young companies during the product development phase. “Raising capital has just been really, really difficult — really tricky,” Sison observes. “Hopefully, that’s going to be changing in the next couple of months [...] A lot of uncertainty that has been present is going away.” “With those companies that are in the capital-raise phase, I really like to sit down with them and say, ‘Remember [...] the FDA is approving a drug product that’s going to be on the shelf — not your business plan, not a stack of clinical data, not your correspondence with the FDA, but a product,’” he adds. “All of those things are important, but at the end of the day, you need a product .” Sison also provides insight into the critical conversations he has with clients to help ensure their success. This initial process includes creating a “target product profile” that outlines what the product needs to be. From there, he works with clients to “devise a drug product development plan in parallel with [their] clinical development plan” before crafting a “drug product development strategy.” He stresses the importance of following these steps as early as possible. “When you’re talking to investors, you need to be able to show them that you know the development process and you understand the costs ,” he shares, “It’s the costs, really, that are important up front.” Hosted by Crowley Law LLC Founder and Managing Partner Philip Crowley, the “From Lab to Patient, Garage to Market” podcast explores the critical issues and concerns impacting the biotech, life sciences and startup markets by offering fresh perspectives from industry leaders and experts. It is available on YouTube, LinkedIn, Facebook, Apple Podcasts, Spotify, all the major podcast channels and at CrowleyLawLLC.com .

Note: The foregoing may constitute attorney advertising under applicable bar rules.

Words on a Reciprocal Relationship

Grimes & Yvon LLP

“As attorneys, our reputation is one of our primary assets, so we must have a trustworthy referral network. Crowley Law LLC has been a go-to referral firm for nearly a decade and remains a tremendous resource. Phil is so tapped into the industry and has such great experience that we know our clients will always be in good hands. Even when a client’s request falls outside Crowley Law LLC’s direct services, Philip’s extensive network of contacts ensures that clients will be directed to the most appropriate resources to fulfill their needs. “I once had a friend from grad school — who is a very successful academic scientist and leader in his field — contact me for advice after he developed a compound with therapeutic potential and sought to form a company. The first thing I said was, ‘Call Phil Crowley!’ Phil was able to assist him in advancing his academic work into a company and potential commercial endeavor. Phil’s expertise, guidance and support put him in the best position to succeed. “Phil is a solid, forward-thinking person who strives to do the right thing. I’m always comfortable and confident referring my clients to him.”

–Anne-Marie Yvon

908-460-5529 — 3

Made with FlippingBook Ebook Creator